BCL2L12 and glioblastoma: BCL2L12 can bind to p53 in the nucleus to prevent association with p53 targets [67] and also acts as anti‐apoptotic factor in glioblastoma by inhibiting caspases 3 and 7 in the cytoplasm [68, 69, 70].